Drug Discovery and Development: Vertebral Technologies, Inc.

• Publication date: June 2012
• Report size: 17 pages

This report is a source for data, analysis and actionable intelligence on the Vertebral Technologies, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product descripti...

This report is a source for data, analysis and actionable intelligence on the Vertebral Technologies, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Drug Discovery And Development Industry in the United States

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Vertebral Technologies, Inc. - Major Products and Services 5
Vertebral Technologies, Inc. Pipeline Products by Equipment Type 6
Vertebral Technologies, Inc. Pipeline Products by Development Stage 7
Vertebral Technologies, Inc. Pipeline Products by Therapy Area 8
InterCushion 9
Product Status 9
Product Description 9
Product Patent Details 9
Interfuse - Anterior System 9
Product Status 9
Product Description 10
Interfuse - Lateral System 10
Product Status 10
Product Description 10
Vertebral Technologies, Inc. - Top Competitors 11
Vertebral Technologies, Inc. - Operations and Subsidiaries 12
Head Office 12
Appendix 13
Methodology 13
About GlobalData 13
Contact Us 13
Disclaimer 13


List of Tables

Vertebral Technologies, Inc., Major development 1
Vertebral Technologies, Inc. Key Pipeline Products by Equipment Type 1
Vertebral Technologies, Inc. Key Pipeline Products by Therapy Area 1
Vertebral Technologies, Inc. Key Pipeline Products by Development Stage 1
Vertebral Technologies, Inc. Key Pipeline Products by Trial Phase 1
Vertebral Technologies, Inc., Major development 4
Vertebral Technologies, Inc., Major Products and Services 5
Vertebral Technologies, Inc. Number of Pipeline Products by Equipment Type 6
Vertebral Technologies, Inc. Pipeline Products by Equipment Type 6
Vertebral Technologies, Inc. Number of Pipeline Products by Development Stage 7
Vertebral Technologies, Inc. Pipeline Products by Development Stage 7
Vertebral Technologies, Inc. Number of Pipeline Products by Therapy Area 8
Vertebral Technologies, Inc. Pipeline Products by Therapy Area 8
InterCushion - Product Status 9
InterCushion - Product Description 9
InterCushion - Patent Details 9
Interfuse - Anterior System - Product Status 9
Interfuse - Anterior System - Product Description 10
Interfuse - Lateral System - Product Status 10
Interfuse - Lateral System - Product Description 10


List of Figures

Vertebral Technologies, Inc. Pipeline Products by Equipment Type 6
Vertebral Technologies, Inc. Pipeline Products by Development Stage 7
Vertebral Technologies, Inc. Pipeline Products by Therapy Area 8

Companies mentioned TranS1 Inc.
VertiFlex
Spinal USA
Spine Surgical Innovation
SyntheMed, Inc.

Clinical Trial in United States

United States Phase I Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : United States

United States Total Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : United States

United States Phase Ii Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : United States

United States Phase Iii Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : United States

United States Phase Iv Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : United States